Please assess the completion status of the following clinical trial:

Trial Title: Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~A patient's study eye must meet the following criteria to be eligible for inclusion in the study:~* 18 years of age or older~* Signs and symptoms of DED~* Consent to treat with topical immunomodulator~* Willing and able to comply with clinic visits and study related procedures~* Willing and able to sign the informed consent form~Exclusion Criteria:~A patient who meets any of the following criteria will be excluded from the study:~* Patients under the age of 18.~* Pregnancy (must be ruled out in women of child-bearing age with pregnancy test)~* Active infectious systemic disease~* Active infectious ocular or extraocular disease~* Altered nasolacrimal flow of either acquired, induced, or congenital origin~* Hypersensitivity to dexamethasone~* Patients who have been on topical immunomodulating agents in the previous 3 months to their baseline visit~* Patient being treated with either topical, oral, or intravenous immunosuppressive agents, immunomodulating agents, or steroid (including NSAIDS)~* Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Xiidra Only Group (Type: ACTIVE_COMPARATOR): Patients with dry eye disease Xiidra only
- Xiidra + Dextenza Group (Type: EXPERIMENTAL): Patients with dry eye disease Xiidra + Dextenza

Based on this trial design, predict the completion outcome and termination type (if applicable).